Adial Pharmaceuticals Stock Performance

ADIL Stock  USD 3.12  0.09  2.97%   
The firm shows a Beta (market volatility) of 0.71, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Adial Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Adial Pharmaceuticals is expected to be smaller as well. At this point, Adial Pharmaceuticals has a negative expected return of -1.47%. Please make sure to confirm Adial Pharmaceuticals' skewness, and the relationship between the treynor ratio and rate of daily change , to decide if Adial Pharmaceuticals performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Adial Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward indicators remain quite persistent which may send shares a bit higher in March 2026. The latest mess may also be a sign of long-standing up-swing for the company institutional investors. ...more

Actual Historical Performance (%)

One Day Return
(1.94)
Five Day Return
(19.20)
Year To Date Return
(49.50)
Ten Year Return
(99.88)
All Time Return
(99.88)
Last Split Factor
1:25
Last Split Date
2026-02-06
1
Will Adial Pharmaceuticals Inc. stock deliver strong dividend growth - July 2025 Outlook Free Technical Pattern Based Buy Signals - newser.com
11/20/2025
2
Adial Pharmaceuticals Secures 2.86M Through Warrant Agreement - TipRanks
12/01/2025
3
Litchfield Hills Research Forecasts ADIL FY2025 Earnings
12/12/2025
4
Adial Pharmaceuticals announces immediate resignation of board director - TipRanks
01/06/2026
5
Adial Pharmaceuticals Announces Publication of International PCT Patent Application to Protect Core Assets and Extend IP Exclusivity to at least 2045 - Chartmil...
01/14/2026
6
Thermo Fisher Scientific Inks Deal to Manufacture Adial Pharmaceuticals ADO4 - MSN
01/23/2026
7
Adial Pharmaceuticals announces 1-for-25 reverse stock split shares down
02/03/2026
8
Why Is Adial Pharmaceuticals Stock Down Today - TipRanks
02/05/2026

Adial Pharmaceuticals Relative Risk vs. Return Landscape

If you would invest  798.00  in Adial Pharmaceuticals on November 13, 2025 and sell it today you would lose (495.00) from holding Adial Pharmaceuticals or give up 62.03% of portfolio value over 90 days. Adial Pharmaceuticals is currently does not generate positive expected returns and assumes 4.9109% risk (volatility on return distribution) over the 90 days horizon. In different words, 44% of stocks are less volatile than Adial, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Adial Pharmaceuticals is expected to under-perform the market. In addition to that, the company is 6.31 times more volatile than its market benchmark. It trades about -0.3 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of volatility.

Adial Pharmaceuticals Target Price Odds to finish over Current Price

The tendency of Adial Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 3.12 90 days 3.12 
close to 99
Based on a normal probability distribution, the odds of Adial Pharmaceuticals to move above the current price in 90 days from now is close to 99 (This Adial Pharmaceuticals probability density function shows the probability of Adial Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Adial Pharmaceuticals has a beta of 0.71. This suggests as returns on the market go up, Adial Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Adial Pharmaceuticals will be expected to be much smaller as well. Additionally Adial Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Adial Pharmaceuticals Price Density   
       Price  

Predictive Modules for Adial Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Adial Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.142.717.62
Details
Intrinsic
Valuation
LowRealHigh
2.7315.7820.69
Details
3 Analysts
Consensus
LowTargetHigh
49.2954.1760.13
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-3.25-3.12-3
Details

Adial Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Adial Pharmaceuticals is not an exception. The market had few large corrections towards the Adial Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Adial Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Adial Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-1.47
β
Beta against Dow Jones0.71
σ
Overall volatility
1.38
Ir
Information ratio -0.32

Adial Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Adial Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Adial Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Adial Pharmaceuticals generated a negative expected return over the last 90 days
Adial Pharmaceuticals has high historical volatility and very poor performance
Adial Pharmaceuticals has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (13.2 M) with profit before overhead, payroll, taxes, and interest of 0.
Adial Pharmaceuticals currently holds about 9.16 M in cash with (6.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.35.
Adial Pharmaceuticals has a frail financial position based on the latest SEC disclosures
Latest headline from news.google.com: Why Is Adial Pharmaceuticals Stock Down Today - TipRanks

Adial Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Adial Stock often depends not only on the future outlook of the current and potential Adial Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Adial Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding743.5 K
Cash And Short Term Investments3.8 M

Adial Pharmaceuticals Fundamentals Growth

Adial Stock prices reflect investors' perceptions of the future prospects and financial health of Adial Pharmaceuticals, and Adial Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Adial Stock performance.

About Adial Pharmaceuticals Performance

By examining Adial Pharmaceuticals' fundamental ratios, stakeholders can obtain critical insights into Adial Pharmaceuticals' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Adial Pharmaceuticals is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Last ReportedProjected for Next Year
Return On Tangible Assets(2.36)(2.47)
Return On Capital Employed(2.34)(2.46)
Return On Assets(2.35)(2.47)
Return On Equity(3.73)(3.92)

Things to note about Adial Pharmaceuticals performance evaluation

Checking the ongoing alerts about Adial Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Adial Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Adial Pharmaceuticals generated a negative expected return over the last 90 days
Adial Pharmaceuticals has high historical volatility and very poor performance
Adial Pharmaceuticals has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (13.2 M) with profit before overhead, payroll, taxes, and interest of 0.
Adial Pharmaceuticals currently holds about 9.16 M in cash with (6.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.35.
Adial Pharmaceuticals has a frail financial position based on the latest SEC disclosures
Latest headline from news.google.com: Why Is Adial Pharmaceuticals Stock Down Today - TipRanks
Evaluating Adial Pharmaceuticals' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Adial Pharmaceuticals' stock performance include:
  • Analyzing Adial Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Adial Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
  • Examining Adial Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Adial Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Adial Pharmaceuticals' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Adial Pharmaceuticals' stock. These opinions can provide insight into Adial Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Adial Pharmaceuticals' stock performance is not an exact science, and many factors can impact Adial Pharmaceuticals' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Adial Pharmaceuticals is a strong investment it is important to analyze Adial Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Adial Pharmaceuticals' future performance. For an informed investment choice regarding Adial Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adial Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Adial Stock please use our How to buy in Adial Stock guide.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adial Pharmaceuticals. If investors know Adial will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Adial Pharmaceuticals assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(14.88)
Return On Assets
(0.79)
Return On Equity
(1.55)
Adial Pharmaceuticals's market price often diverges from its book value, the accounting figure shown on Adial's balance sheet. Smart investors calculate Adial Pharmaceuticals' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Adial Pharmaceuticals' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that Adial Pharmaceuticals' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Adial Pharmaceuticals represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Adial Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.